Assessment of macrophage apoptosis inhibitor (AIM), monocyte chemotactic protein-1 (MCP-1) and C reactive protein (CRP) levels in patients with metabolic syndrome
2020 ◽
Vol 18
(4)
◽
pp. 197-205
◽
2007 ◽
Vol 29
(3)
◽
pp. 131-136
◽
2014 ◽
Vol 7
(6)
◽
pp. 1647-1652
◽
2014 ◽
Vol 20
(5)
◽
pp. A42-A42
Keyword(s):